| CAS No. | 1023-01-4 |
| Molecular Formula | C14H25BrN2 |
| Molecular Weight | 301.27 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
The molecular framework of 2-(4-bromophenyl)-6-methylimidazo[1,2-<I>a</I>]pyridine (C14H25BrN2) is characterized by a nitrile group, bromine substitution. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.
CATO supplies 2-(4-bromophenyl)-6-methylimidazo[1,2-<I>a</I>]pyridine (CAS 1023-01-4), a certified reference material (molecular formula C14H25BrN2, MW 301.27 g/mol) for analytical method development and quality control.
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
As a certified reference material (CRM), 2-(4-bromophenyl)-6-methylimidazo[1,2-<I>a</I>]pyridine meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
| Molecular Formula | C14H25BrN2 |
| Molecular Weight | 301.27 g/mol |
| Appearance | White to pale yellow crystalline powder. (slight halide-like odor) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 3.0 |
| UV Absorption | UV-absorbing |
| CAS Registry Year (est.) | 1957 |
| Halogen Content | Br-containing |
| Nitrogen Atoms | 2 |